CL
GMAB icon

Choreo LLC’s Genmab GMAB Stock Holding History

Choreo LLC’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$668K Sell
24,889
-216
-0.9% -$6.47K 0.01% 795
2025
Q4 		$791K Sell
25,105
-4,258
-15% -$133K 0.01% 704
2025
Q3 		$901K Buy
29,363
+3,569
+14% +$87K 0.01% 648
2025
Q2 		$533K Sell
25,794
-246
-0.9% -$5.05K 0.01% 862
2025
Q1 		$510K Buy
26,040
+4,226
+19% +$88.6K 0.01% 819
2024
Q4 		$453K Sell
21,814
-6,755
-24% -$148K 0.01% 957
2024
Q3 		$690K Sell
28,569
-2,631
-8% -$70.3K 0.01% 744
2024
Q2 		$776K Buy
+31,200
New +$885K 0.01% 619

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Choreo LLC's GMAB Position: Q1 2026 in Review

Choreo LLC reduced its Genmab (GMAB) stake by 0.86% in Q1 2026, selling an estimated $6.47K and leaving 24,889 shares worth $668K. The position accounts for 0.01% of the portfolio, ranked #795.

Choreo LLC first reported a position in GMAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $901K in Q3 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Choreo LLC held 24,889 shares of Genmab worth $668K as of Q1 2026.
  • Choreo LLC sold 216 Genmab shares in Q1 2026, an estimated $6.47K.
  • Genmab made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #795 holding.
  • Choreo LLC first reported a position in Genmab in Q2 2024 and has held it in 8 quarters since.
  • Choreo LLC's Genmab position peaked at $901K in Q3 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.